Filing Details
- Accession Number:
- 0001161697-24-000253
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-06-05 17:00:21
- Reporting Period:
- 2024-06-03
- Accepted Time:
- 2024-06-05 17:00:21
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1369568 | Catalyst Pharmaceuticals Inc. | CPRX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1871470 | Molly Harper | 355 Alhambra Circle Suite 801 Coral Gables FL 33134 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.001 Per Share | Disposition | 2024-06-03 | 5,333 | $16.30 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Shares were sold for personal reasons and not as a result of any disagreement with the Company. Ms. Harper remains a director of the Company.
- Represents a weighted average price for the shares sold. Shares were sold in a range between $16.26 and $16.34 per share.
Billionaire Hedge Funds
